Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

STATROL

NEOMYCIN SULFATE; POLYMYXIN B SULFATE

Standard Dose
EQ 3.5MG BASE/GM;10,000 UNITS/GM
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview STATROL is listed in Drugs@FDA under application 050344 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient NEOMYCIN SULFATE; POLYMYXIN B SULFATE Form and strength OINTMENT;OPHTHALMIC - EQ 3.5MG BASE/GM;10,000 UNITS/GM Sponsor ALCON Submission history Latest submission status date: 1999-09-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview STATROL is listed in Drugs@FDA under application 050344 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient NEOMYCIN SULFATE; POLYMYXIN B SULFATE Form and strength OINTMENT;OPHTHALMIC - EQ 3.5MG BASE/GM;10,000 UNITS/GM Sponsor ALCON Submission history Latest submission status date: 1999-09-28 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
STATROL (NEOMYCIN SULFATE; POLYMYXIN B SULFATE) | Drug Monograph | MedicHelpline